Cancer-triggered systemic disease and therapeutic targets

Yihai Cao1

  • 1Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Solnavägen 9, Stockholm, 171 65 Sweden.

Holistic Integrative Oncology
|March 14, 2024
PubMed

Insights

Cancer causes systemic diseases via metastasis, paraneoplastic syndromes (PNS), and cancer cachexia (CCA). This review explores mechanisms and treatments for overlooked PNS and CCA.

Area of Science:

  • Oncology
  • Systemic effects of cancer

Background:

  • Cancer induces systemic diseases through metastasis, paraneoplastic syndromes (PNS), and cancer cachexia (CCA).
  • While metastasis is well-researched, PNS and CCA are relatively overlooked.
  • Effective treatments for PNS and CCA in cancer patients are currently lacking.

Purpose of the Study:

  • To discuss mechanistic insights into paraneoplastic syndromes (PNS) and cancer cachexia (CCA).
  • To review current advances in the development of potential therapeutic interventions for PNS and CCA.

Main Methods:

  • Literature review focusing on the mechanisms of PNS and CCA.
  • Analysis of current research on therapeutic strategies for PNS and CCA.

Main Results:

  • PNS affects multiple organ systems (endocrine, gastrointestinal, hematologic, neurologic, dermatologic, ophthalmologic).
  • CCA is characterized by anorexia, progressive body weight loss, adipose, and muscle atrophy.
  • Mechanistic understanding of PNS and CCA is limited, hindering treatment development.

Conclusions:

  • Further research into the mechanisms of PNS and CCA is crucial.
  • Development of novel therapeutic interventions for PNS and CCA is urgently needed.
  • Addressing PNS and CCA can improve patient outcomes in cancer care.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
365
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K